<DOC>
	<DOC>NCT00708682</DOC>
	<brief_summary>The purpose of this study will be to evaluate safety, tolerability and immunogenicity of 13-valent pneumococcal vaccine in healthy infants given with routine pediatric vaccinations in Mexico.</brief_summary>
	<brief_title>Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy 2 month infants, available for entire study period and parent/legal guardian reachable by telephone Able to complete three blood draws during study At least 3.5 kg at enrollment Previous vaccination (except Hepatitis, BCG), contraindication or allergic reaction to vaccines Immune deficiency, bleeding disorder or significant chronic medical condition</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>98 Days</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>